Mitochondrial disease
Gene: SLC25A20
Carnitine-acylcarnitine translocase deficiency is a rare autosomal recessive metabolic disorder of long-chain fatty acid oxidation. Metabolic consequences include hypoketotic hypoglycemia under fasting conditions, hyperammonemia, elevated creatine kinase and transaminases, dicarboxylic aciduria, very low free carnitine and abnormal acylcarnitine profile with marked elevation of the long-chain acylcarnitines. Clinical features include neurologic abnormalities, cardiomyopathy and arrhythmias, skeletal muscle damage, and liver dysfunction. Most patients become symptomatic in the neonatal period with a rapidly progressive deterioration and a high mortality rate. However, presentations at a later age with a milder phenotype have been reported. Well established gene-disease association.Created: 30 Dec 2020, 9:49 p.m. | Last Modified: 30 Dec 2020, 9:49 p.m.
Panel Version: 0.5879
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Carnitine-acylcarnitine translocase deficiency, MIM# 212138
Publications
>3 cases. Condition is a recessive disorder of mitochondrial fatty acid oxidation.
Sources: Literature, NHS GMSCreated: 20 Mar 2020, 8:19 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Carnitine-acylcarnitine translocase deficiency MIM#212138
Publications
Tag treatable tag was added to gene: SLC25A20.
Gene: slc25a20 has been classified as Green List (High Evidence).
Gene: slc25a20 has been classified as Green List (High Evidence).
gene: SLC25A20 was added gene: SLC25A20 was added to Mitochondrial disease. Sources: Literature,NHS GMS Mode of inheritance for gene: SLC25A20 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: SLC25A20 were set to 9399886; 31108048; 25778941 Phenotypes for gene: SLC25A20 were set to Carnitine-acylcarnitine translocase deficiency MIM#212138 Review for gene: SLC25A20 was set to GREEN